BIO logo

Bio-Rad Laboratories, Inc. (BIO) Cash from operations

annual CFO:

$454.60M+$79.66M(+21.25%)
December 31, 2024

Summary

  • As of today (September 14, 2025), BIO annual cash flow from operations is $454.60 million, with the most recent change of +$79.66 million (+21.25%) on December 31, 2024.
  • During the last 3 years, BIO annual CFO has risen by +$870.04 million (+209.43%).
  • BIO annual CFO is now -68.34% below its all-time high of $1.44 billion, reached on December 31, 2022.

Performance

BIO Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

quarterly CFO:

$116.50M-$13.40M(-10.32%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BIO quarterly cash flow from operations is $116.50 million, with the most recent change of -$13.40 million (-10.32%) on June 30, 2025.
  • Over the past year, BIO quarterly CFO has increased by +$18.85 million (+19.31%).
  • BIO quarterly CFO is now -91.18% below its all-time high of $1.32 billion, reached on December 31, 2022.

Performance

BIO quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

TTM CFO:

$534.18M+$18.85M(+3.66%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BIO TTM cash flow from operations is $534.18 million, with the most recent change of +$18.85 million (+3.66%) on June 30, 2025.
  • Over the past year, BIO TTM CFO has increased by +$580.23 million (+1260.07%).
  • BIO TTM CFO is now -66.93% below its all-time high of $1.62 billion, reached on September 30, 2023.

Performance

BIO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BIO Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.3%+19.3%+1260.1%
3 y3 years+209.4%-69.9%-31.6%
5 y5 years-0.7%+167.2%+2430.8%

BIO Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-68.3%+209.4%-91.2%+108.6%-66.9%+166.8%
5 y5-year-68.3%+209.4%-91.2%+108.6%-66.9%+166.8%
alltimeall time-68.3%+209.4%-91.2%+108.6%-66.9%+166.8%

BIO Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$116.50M(-10.3%)
$534.18M(+3.7%)
Mar 2025
-
$129.90M(+4.6%)
$515.33M(+13.4%)
Dec 2024
$454.60M(+21.2%)
$124.17M(-24.1%)
$454.60M(+10.5%)
Sep 2024
-
$163.61M(+67.6%)
$411.48M(-993.6%)
Jun 2024
-
$97.65M(+41.2%)
-$46.05M(-113.9%)
Mar 2024
-
$69.17M(-14.6%)
$332.16M(-11.4%)
Dec 2023
$374.94M(-73.9%)
$81.05M(-127.6%)
$374.94M(-76.8%)
Sep 2023
-
-$293.92M(-161.8%)
$1.62B(+189.0%)
Jun 2023
-
$475.85M(+325.0%)
$558.92M(+19.0%)
Mar 2023
-
$111.96M(-91.5%)
$469.76M(-67.3%)
Dec 2022
$1.44B(-445.7%)
$1.32B(-197.9%)
$1.44B(-279.7%)
Sep 2022
-
-$1.35B(-449.2%)
-$799.24M(-202.3%)
Jun 2022
-
$386.69M(-64.1%)
$781.27M(+42.3%)
Mar 2022
-
$1.08B(-218.0%)
$549.21M(-232.2%)
Dec 2021
-$415.44M(-172.2%)
-$914.03M(-496.8%)
-$415.44M(-126.4%)
Sep 2021
-
$230.36M(+49.0%)
$1.57B(+39.7%)
Jun 2021
-
$154.62M(+36.1%)
$1.13B(+41.1%)
Mar 2021
-
$113.61M(-89.4%)
$797.93M(+38.7%)
Dec 2020
$575.33M(+25.6%)
$1.07B(-595.2%)
$575.33M(-269.4%)
Sep 2020
-
-$217.04M(+25.1%)
-$339.70M(+1382.3%)
Jun 2020
-
-$173.48M(+59.2%)
-$22.92M(-107.5%)
Mar 2020
-
-$108.99M(-168.2%)
$305.96M(-33.2%)
Dec 2019
$457.90M(+60.4%)
$159.80M(+60.2%)
$457.90M(+13.6%)
Sep 2019
-
$99.75M(-35.8%)
$403.10M(+10.2%)
Jun 2019
-
$155.40M(+261.9%)
$365.63M(+26.9%)
Mar 2019
-
$42.94M(-59.1%)
$288.09M(+0.9%)
Dec 2018
$285.49M(+174.2%)
$105.01M(+68.6%)
$285.49M(+14.3%)
Sep 2018
-
$62.28M(-20.0%)
$249.85M(+15.6%)
Jun 2018
-
$77.86M(+93.0%)
$216.05M(+7.7%)
Mar 2018
-
$40.35M(-41.8%)
$200.69M(+92.7%)
Dec 2017
$104.14M(-51.9%)
$69.36M(+143.6%)
$104.14M(-19.8%)
Sep 2017
-
$28.48M(-54.4%)
$129.89M(-15.1%)
Jun 2017
-
$62.50M(-211.2%)
$153.02M(-8.7%)
Mar 2017
-
-$56.20M(-159.1%)
$167.68M(-22.5%)
Dec 2016
$216.43M(+16.2%)
$95.12M(+84.3%)
$216.43M(+37.6%)
Sep 2016
-
$51.61M(-33.1%)
$157.27M(-16.3%)
Jun 2016
-
$77.16M(-1135.9%)
$187.94M(+25.9%)
Mar 2016
-
-$7.45M(-120.7%)
$149.32M(-19.8%)
Dec 2015
$186.21M(-31.9%)
$35.95M(-56.3%)
$186.21M(-2.5%)
Sep 2015
-
$82.28M(+113.5%)
$191.00M(-0.2%)
Jun 2015
-
$38.53M(+30.9%)
$191.47M(-18.1%)
Mar 2015
-
$29.45M(-27.7%)
$233.84M(-14.4%)
Dec 2014
$273.31M(+55.8%)
$40.74M(-50.8%)
$273.31M(-10.7%)
Sep 2014
-
$82.75M(+2.3%)
$306.01M(+7.0%)
Jun 2014
-
$80.90M(+17.4%)
$286.11M(+27.8%)
Mar 2014
-
$68.92M(-6.2%)
$223.90M(+27.6%)
Dec 2013
$175.48M(-37.1%)
$73.44M(+16.9%)
$175.48M(-12.6%)
Sep 2013
-
$62.85M(+236.3%)
$200.69M(-4.1%)
Jun 2013
-
$18.69M(-8.8%)
$209.18M(-20.8%)
Mar 2013
-
$20.50M(-79.2%)
$264.14M(-5.3%)
Dec 2012
$278.90M(+7.3%)
$98.65M(+38.3%)
$278.90M(+7.8%)
Sep 2012
-
$71.34M(-3.1%)
$258.82M(+8.5%)
Jun 2012
-
$73.64M(+108.9%)
$238.64M(-13.3%)
Mar 2012
-
$35.26M(-55.1%)
$275.29M(+6.0%)
Dec 2011
$259.82M(+15.0%)
$78.58M(+53.6%)
$259.82M(-7.7%)
Sep 2011
-
$51.16M(-53.6%)
$281.63M(-5.3%)
Jun 2011
-
$110.30M(+457.6%)
$297.33M(+33.1%)
Mar 2011
-
$19.78M(-80.3%)
$223.42M(-1.1%)
Dec 2010
$225.91M(-30.5%)
$100.39M(+50.1%)
$225.91M(-6.4%)
Sep 2010
-
$66.87M(+83.8%)
$241.24M(-11.3%)
Jun 2010
-
$36.39M(+63.4%)
$271.87M(-20.3%)
Mar 2010
-
$22.27M(-80.8%)
$340.97M(+4.9%)
Dec 2009
$325.07M(+69.9%)
$115.72M(+18.7%)
$325.07M(+13.0%)
Sep 2009
-
$97.49M(-7.6%)
$287.69M(+21.7%)
Jun 2009
-
$105.49M(+1555.8%)
$236.32M(+18.2%)
Mar 2009
-
$6.37M(-91.9%)
$199.92M(+4.5%)
Dec 2008
$191.37M(-0.1%)
$78.34M(+69.9%)
$191.37M(-11.5%)
Sep 2008
-
$46.12M(-33.2%)
$216.18M(-3.9%)
Jun 2008
-
$69.09M(-3273.5%)
$225.06M(+11.4%)
Mar 2008
-
-$2.18M(-102.1%)
$202.04M(+5.5%)
Dec 2007
$191.58M
$103.15M(+87.6%)
$191.58M(+33.7%)
Sep 2007
-
$55.00M(+19.4%)
$143.26M(+2.2%)
Jun 2007
-
$46.07M(-464.5%)
$140.14M(-5.1%)
DateAnnualQuarterlyTTM
Mar 2007
-
-$12.64M(-123.1%)
$147.63M(+24.9%)
Dec 2006
$118.20M(+9.2%)
$54.83M(+5.7%)
$118.20M(+4.8%)
Sep 2006
-
$51.87M(-3.2%)
$112.76M(+22.6%)
Jun 2006
-
$53.56M(-227.3%)
$91.96M(+122.5%)
Mar 2006
-
-$42.07M(-185.2%)
$41.33M(-61.8%)
Dec 2005
$108.28M(-12.0%)
$49.39M(+59.0%)
$108.28M(-1.5%)
Sep 2005
-
$31.07M(+958.7%)
$109.92M(+6.3%)
Jun 2005
-
$2.94M(-88.2%)
$103.37M(-14.3%)
Mar 2005
-
$24.88M(-51.2%)
$120.67M(-2.0%)
Dec 2004
$123.09M(-3.6%)
$51.03M(+108.1%)
$123.09M(+11.8%)
Sep 2004
-
$24.52M(+21.2%)
$110.14M(-14.4%)
Jun 2004
-
$20.24M(-25.9%)
$128.59M(-3.5%)
Mar 2004
-
$27.31M(-28.3%)
$133.23M(+4.4%)
Dec 2003
$127.64M(+21.8%)
$38.08M(-11.4%)
$127.64M(+2.8%)
Sep 2003
-
$42.97M(+72.8%)
$124.21M(+9.5%)
Jun 2003
-
$24.87M(+14.5%)
$113.42M(+4.6%)
Mar 2003
-
$21.72M(-37.3%)
$108.38M(+3.4%)
Dec 2002
$104.80M(+5.3%)
$34.65M(+7.7%)
$104.80M(-5.2%)
Sep 2002
-
$32.18M(+62.2%)
$110.57M(+10.0%)
Jun 2002
-
$19.83M(+9.4%)
$100.47M(-13.0%)
Mar 2002
-
$18.14M(-55.1%)
$115.42M(+16.0%)
Dec 2001
$99.50M(+310.4%)
$40.42M(+83.0%)
$99.50M(+53.2%)
Sep 2001
-
$22.08M(-36.5%)
$64.97M(+31.8%)
Jun 2001
-
$34.78M(+1470.4%)
$49.28M(+52.6%)
Mar 2001
-
$2.21M(-62.3%)
$32.28M(+33.1%)
Dec 2000
$24.25M(-46.1%)
$5.88M(-8.1%)
$24.25M(-40.0%)
Sep 2000
-
$6.40M(-64.0%)
$40.43M(-7.8%)
Jun 2000
-
$17.79M(-405.5%)
$43.84M(+16.1%)
Mar 2000
-
-$5.82M(-126.4%)
$37.75M(-16.1%)
Dec 1999
$44.98M(+64.6%)
$22.07M(+125.1%)
$44.98M(+30.8%)
Sep 1999
-
$9.80M(-16.2%)
$34.39M(+4.0%)
Jun 1999
-
$11.70M(+733.0%)
$33.06M(+14.7%)
Mar 1999
-
$1.41M(-87.8%)
$28.83M(+5.5%)
Dec 1998
$27.34M(+29.5%)
$11.47M(+35.4%)
$27.34M(+33.6%)
Sep 1998
-
$8.47M(+13.4%)
$20.46M(-6.6%)
Jun 1998
-
$7.47M(-8594.3%)
$21.91M(+0.9%)
Mar 1998
-
-$88.00K(-101.9%)
$21.72M(+2.9%)
Dec 1997
$21.11M(-36.3%)
$4.60M(-53.7%)
$21.11M(-15.5%)
Sep 1997
-
$9.92M(+36.2%)
$24.99M(+51.8%)
Jun 1997
-
$7.29M(-1138.3%)
$16.47M(-31.6%)
Mar 1997
-
-$702.00K(-108.3%)
$24.08M(-27.4%)
Dec 1996
$33.15M(-13.3%)
$8.48M(+505.9%)
$33.18M(-16.2%)
Sep 1996
-
$1.40M(-90.6%)
$39.60M(-8.8%)
Jun 1996
-
$14.90M(+77.4%)
$43.40M(+13.9%)
Mar 1996
-
$8.40M(-43.6%)
$38.10M(-0.3%)
Dec 1995
$38.23M(-20.8%)
$14.90M(+186.5%)
$38.20M(+9.8%)
Sep 1995
-
$5.20M(-45.8%)
$34.80M(-6.2%)
Jun 1995
-
$9.60M(+12.9%)
$37.10M(-11.2%)
Mar 1995
-
$8.50M(-26.1%)
$41.80M(-13.5%)
Dec 1994
$48.27M(+114.3%)
$11.50M(+53.3%)
$48.30M(-15.9%)
Sep 1994
-
$7.50M(-47.6%)
$57.40M(+5.1%)
Jun 1994
-
$14.30M(-4.7%)
$54.60M(+37.9%)
Mar 1994
-
$15.00M(-27.2%)
$39.60M(+76.0%)
Dec 1993
$22.53M(+468.1%)
$20.60M(+338.3%)
$22.50M(-355.7%)
Sep 1993
-
$4.70M(-771.4%)
-$8.80M(-269.2%)
Jun 1993
-
-$700.00K(-66.7%)
$5.20M(+23.8%)
Mar 1993
-
-$2.10M(-80.4%)
$4.20M(+5.0%)
Dec 1992
$3.96M(-4.1%)
-$10.70M(-157.2%)
$4.00M(-81.6%)
Sep 1992
-
$18.70M(-1200.0%)
$21.70M(+933.3%)
Jun 1992
-
-$1.70M(-26.1%)
$2.10M(-63.2%)
Mar 1992
-
-$2.30M(-132.9%)
$5.70M(+39.0%)
Dec 1991
$4.14M(-65.8%)
$7.00M(-877.8%)
$4.10M(-1466.7%)
Sep 1991
-
-$900.00K(-147.4%)
-$300.00K(-105.9%)
Jun 1991
-
$1.90M(-148.7%)
$5.10M(+34.2%)
Mar 1991
-
-$3.90M(-250.0%)
$3.80M(-68.6%)
Dec 1990
$12.09M(+39.8%)
$2.60M(-42.2%)
$12.10M(+27.4%)
Sep 1990
-
$4.50M(+650.0%)
$9.50M(+90.0%)
Jun 1990
-
$600.00K(-86.4%)
$5.00M(+13.6%)
Mar 1990
-
$4.40M
$4.40M
Dec 1988
$8.64M(-242.6%)
-
-
Dec 1987
-$6.06M(-200.0%)
-
-
Dec 1986
$6.07M(+96.2%)
-
-
Dec 1985
$3.09M(-222.6%)
-
-
Dec 1984
-$2.52M
-
-

FAQ

  • What is Bio-Rad Laboratories, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. annual CFO year-on-year change?
  • What is Bio-Rad Laboratories, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. quarterly CFO year-on-year change?
  • What is Bio-Rad Laboratories, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. TTM CFO year-on-year change?

What is Bio-Rad Laboratories, Inc. annual cash flow from operations?

The current annual CFO of BIO is $454.60M

What is the all time high annual CFO for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high annual cash flow from operations is $1.44B

What is Bio-Rad Laboratories, Inc. annual CFO year-on-year change?

Over the past year, BIO annual cash flow from operations has changed by +$79.66M (+21.25%)

What is Bio-Rad Laboratories, Inc. quarterly cash flow from operations?

The current quarterly CFO of BIO is $116.50M

What is the all time high quarterly CFO for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high quarterly cash flow from operations is $1.32B

What is Bio-Rad Laboratories, Inc. quarterly CFO year-on-year change?

Over the past year, BIO quarterly cash flow from operations has changed by +$18.85M (+19.31%)

What is Bio-Rad Laboratories, Inc. TTM cash flow from operations?

The current TTM CFO of BIO is $534.18M

What is the all time high TTM CFO for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high TTM cash flow from operations is $1.62B

What is Bio-Rad Laboratories, Inc. TTM CFO year-on-year change?

Over the past year, BIO TTM cash flow from operations has changed by +$580.23M (+1260.07%)
On this page